Skip to content
Facebook Instagram Linkedin

LifeScienceHistory.com

History made daily

  • Home
  • DirectoryExpand
    • General Company Directory
    • CRO Directory
    • CMO Directory
    • Genealogy on Demand
  • News and History
  • Cartoons
  • Small World
  • Earth is a RockExpand
    • Earth is a Rock
    • Earth is a Rock Lyrics
    • Earth is a Rock Lyrics Defined
LifeScienceHistory.com
History made daily
Home / Biotechnology - Page 88

Biotechnology

A cluster of COVID-19 in Beijing, People’s Republic of China was reported
Biotechnology | COVID-19 | Life Science History | WHO

A cluster of COVID-19 in Beijing, People’s Republic of China was reported

On Jun. 13, 2020, officials from the WHO National Health Commission and Beijing Health Commission announced preliminary investigations…

Read More A cluster of COVID-19 in Beijing, People’s Republic of China was reportedContinue

Dr. Reddy’s Laboratories entered into a licensing agreement with Gilead Sciences for Remdesivir
Biotechnology | COVID-19 | Therapeutics

Dr. Reddy’s Laboratories entered into a licensing agreement with Gilead Sciences for Remdesivir

On Jun. 13, 2020, Dr. Reddy’s Laboratories announced that it had entered into a non-exclusive Licensing Agreement with…

Read More Dr. Reddy’s Laboratories entered into a licensing agreement with Gilead Sciences for RemdesivirContinue

CIRM board approved two additional COVID-19 projects
Biotechnology | COVID-19 | Non-Profit Research | Therapeutics

CIRM board approved two additional COVID-19 projects

On Jun. 12, 2020, the California Institute for Regenerative Medicine (CIRM) awarded $349,999 to Dr. Vaithilingaraja Arumugaswami at…

Read More CIRM board approved two additional COVID-19 projectsContinue

The FDA approved drug to treat infants and children with HIV
Biotechnology | CDC | HIV | Therapeutics

The FDA approved drug to treat infants and children with HIV

On Jun. 12, 2020, the U.S. Food and Drug Administration (FDA) approved ViiV Healthcare’s Tivicay (dolutegravir) tablets and…

Read More The FDA approved drug to treat infants and children with HIVContinue

InBios received FDA Emergency Use Authorization for COVID-19 antibody test
Biotechnology | COVID-19 | Diagnostics | FDA

InBios received FDA Emergency Use Authorization for COVID-19 antibody test

On Jun. 11, 2020, InBios announced that it had received Emergency Use Authorization (EUA) from the U.S. Food…

Read More InBios received FDA Emergency Use Authorization for COVID-19 antibody testContinue

NIH researchers identified key genomic features that could differentiate SARS-CoV-2 from other coronaviruses that cause less severe disease
Biotechnology | COVID-19 | Genomics

NIH researchers identified key genomic features that could differentiate SARS-CoV-2 from other coronaviruses that cause less severe disease

On Jun. 11, 2020, a team of researchers from the National Library of Medicine identified genomic features of…

Read More NIH researchers identified key genomic features that could differentiate SARS-CoV-2 from other coronaviruses that cause less severe diseaseContinue

FDA approved Bristol-Myers’ Opdivo’ (nivolumab) for treatment of patients with advanced esophageal squamous cell carcinoma
Biotechnology | FDA | Medicine | Pharmaceutical | Therapeutics

FDA approved Bristol-Myers’ Opdivo’ (nivolumab) for treatment of patients with advanced esophageal squamous cell carcinoma

On Jun. 11, 2020, Bristol-Myers Squibb announced that Opdivo (nivolumab) was approved by the FDA for the treatment…

Read More FDA approved Bristol-Myers’ Opdivo’ (nivolumab) for treatment of patients with advanced esophageal squamous cell carcinomaContinue

Brain cells can harbor and spread HIV virus to the body
Biotechnology | HIV | Therapeutics

Brain cells can harbor and spread HIV virus to the body

On Jun. 11, 2020, researchers have found that astrocytes, a type of brain cell can harbor HIV and…

Read More Brain cells can harbor and spread HIV virus to the bodyContinue

WHO reported cluster of COVID-19 in Beijing, China
Biotechnology | COVID-19 | WHO

WHO reported cluster of COVID-19 in Beijing, China

On Jun. 11, 2020, the World Trade Organizationメs (WTO) reported that it was following up with Chinese authorities…

Read More WHO reported cluster of COVID-19 in Beijing, ChinaContinue

Quidel received BARDA funding to develop point-of-care diagnostic assay that includes COVID-19
Biotechnology | Diagnostics | Infectious Disease | Influenza

Quidel received BARDA funding to develop point-of-care diagnostic assay that includes COVID-19

On Jun. 11, 2020, Quidel announced it had received funding from the Biomedical Advanced Research and Development Authority…

Read More Quidel received BARDA funding to develop point-of-care diagnostic assay that includes COVID-19Continue

Moderna advanced late-stage development of vaccine (mRNA-1273) against COVID-19
Biotechnology | COVID-19 | FDA | Infectious Disease | Vaccine

Moderna advanced late-stage development of vaccine (mRNA-1273) against COVID-19

On Jun. 11, 2020, Moderna announced progress on late-stage development of mRNA-1273, the Company’s mRNA vaccine candidate against…

Read More Moderna advanced late-stage development of vaccine (mRNA-1273) against COVID-19Continue

BioCryst’s galidesivir stops Zika viral replication in primate model
Biotechnology | COVID-19 | Diagnostics | Infectious Disease | Therapeutics

BioCryst’s galidesivir stops Zika viral replication in primate model

On Jun. 11, 2020, BioCryst Pharmaceuticals announced new data published in Science Translational Medicine that show, in a…

Read More BioCryst’s galidesivir stops Zika viral replication in primate modelContinue

Two science publications highlight potential of REGN-COV2 anti-viral antibody cocktail to protect against SARS-CoV-2 escape mutants
Biotechnology | COVID-19 | Therapeutics

Two science publications highlight potential of REGN-COV2 anti-viral antibody cocktail to protect against SARS-CoV-2 escape mutants

On Jun. 11, 2020, Regeneron announced that Science had accepted for publication two papers describing the creation of…

Read More Two science publications highlight potential of REGN-COV2 anti-viral antibody cocktail to protect against SARS-CoV-2 escape mutantsContinue

RedHill Biopharma submited COVID-19 clinical trial application for phase 2/3 study with Opaganib in Russia
Biotechnology | COVID-19 | Therapeutics

RedHill Biopharma submited COVID-19 clinical trial application for phase 2/3 study with Opaganib in Russia

On Jun. 10, 2020, RedHill Biopharma announced it had submitted a Clinical Trial Application (CTA) with the Ministry…

Read More RedHill Biopharma submited COVID-19 clinical trial application for phase 2/3 study with Opaganib in RussiaContinue

COVID-19 mouse model announced to speed search for drugs, vaccines
Biotechnology | COVID-19 | Therapeutics

COVID-19 mouse model announced to speed search for drugs, vaccines

On Jun. 10, 2020, Washington University School of Medicine in St. Louis reported they had developed a mouse…

Read More COVID-19 mouse model announced to speed search for drugs, vaccinesContinue

OraSure received BARDA funding for Coronavirus Antibody ELISA using oral fluid samples
Biotechnology | COVID-19 | Diagnostics | Infectious Disease | Therapeutics

OraSure received BARDA funding for Coronavirus Antibody ELISA using oral fluid samples

On Jun. 10, 2020, OraSure Technologies announced it had been awarded a $629,217 contract from the Biomedical Advanced…

Read More OraSure received BARDA funding for Coronavirus Antibody ELISA using oral fluid samplesContinue

Catalent partnered with Spicona to develop COVID-19 vaccine candidate using GPEx cell line development platform
Biotechnology | COVID-19 | Life Science History | Vaccine

Catalent partnered with Spicona to develop COVID-19 vaccine candidate using GPEx cell line development platform

On Jun. 10, 2020, Catalent announced that it had signed an agreement with Spicona to develop a virus-like…

Read More Catalent partnered with Spicona to develop COVID-19 vaccine candidate using GPEx cell line development platformContinue

Largest catalog of human genetic diversity released
Biotechnology | Diagnostics | Disease | Genomics | Therapeutics

Largest catalog of human genetic diversity released

On Jun. 9, 2020, an international gnomAD team of over 100 scientists released its first set of discoveries…

Read More Largest catalog of human genetic diversity releasedContinue

Illumina received first FDA Emergency Use Authorization for sequencing-based COVID-19 diagnostic test
Biotechnology | Diagnostics | FDA | Genomics

Illumina received first FDA Emergency Use Authorization for sequencing-based COVID-19 diagnostic test

On Jun. 9, 2020, Illumina announced the U.S. Food and Drug Administration (FDA) issued an Emergency Use Authorization…

Read More Illumina received first FDA Emergency Use Authorization for sequencing-based COVID-19 diagnostic testContinue

Quidel’s received amended Emergency Authorization for rapid antigen COVID-19 diagnostic assay
Biotechnology | COVID-19 | FDA

Quidel’s received amended Emergency Authorization for rapid antigen COVID-19 diagnostic assay

On Jun. 9, 2020, Quidel announced it had received an amended Emergency Use Authorization (EUA) from the FDA,…

Read More Quidel’s received amended Emergency Authorization for rapid antigen COVID-19 diagnostic assayContinue

NIH researchers uncovered genes linked to common recurrent fever in children
Biotechnology | Diagnostics | Disease | Genomics | NIH | Therapeutics

NIH researchers uncovered genes linked to common recurrent fever in children

On Jun. 8, 2020, researchers at the National Human Genome Research Institute announced they had discovered clues to…

Read More NIH researchers uncovered genes linked to common recurrent fever in childrenContinue

Intranasal and Versatope signed agreement to develop universal influenza vaccine based on OMV technology
Biotechnology | Infectious Disease | Influenza | Vaccine

Intranasal and Versatope signed agreement to develop universal influenza vaccine based on OMV technology

On Jun. 8, 2020, Intravacc and Versatope announced that they have signed a research service agreement to further…

Read More Intranasal and Versatope signed agreement to develop universal influenza vaccine based on OMV technologyContinue

Two-year PALFORZIA data showed on-going safety and efficacy and continued immunomodulation in patients with peanut allergy
Biotechnology | Life Science History | Therapeutics

Two-year PALFORZIA data showed on-going safety and efficacy and continued immunomodulation in patients with peanut allergy

On Jun. 8, 2020, Aimmune Therapeutics announced two-year data that suggested long-term efficacy of daily treatment with PALFORZIA…

Read More Two-year PALFORZIA data showed on-going safety and efficacy and continued immunomodulation in patients with peanut allergyContinue

OraSure’s Oragene-Dx included in EUA allowing at-home saliva collection for use with Phosphorus SARS-CoV-2 test
Biotechnology | COVID-19 | FDA | Life Science History

OraSure’s Oragene-Dx included in EUA allowing at-home saliva collection for use with Phosphorus SARS-CoV-2 test

On Jun. 8, 2020, OraSure Technologies announced that Phosphorus Diagnostics, a leader in diagnostic and bioinformatic solutions for…

Read More OraSure’s Oragene-Dx included in EUA allowing at-home saliva collection for use with Phosphorus SARS-CoV-2 testContinue

Just – Evotec Biologics partnered with ABL on development of broadly neutralising antibody against HIV
Biotechnology | HIV | NIH

Just – Evotec Biologics partnered with ABL on development of broadly neutralising antibody against HIV

On Jun. 8, 2020, Evotec announced that its Seattle-based subsidiary Just – Evotec Biologics had entered into an…

Read More Just – Evotec Biologics partnered with ABL on development of broadly neutralising antibody against HIVContinue

Unique biorepository stores samples from Alberta COVID-19 patients for future research
Biotechnology | COVID-19 | Infectious Disease | Therapeutics | Vaccine

Unique biorepository stores samples from Alberta COVID-19 patients for future research

On Jun. 5, 2020, the Alberta Precision Laboratories (APL) COVID-19 Biorepository was announced to ensure researchers have the…

Read More Unique biorepository stores samples from Alberta COVID-19 patients for future researchContinue

No clinical benefit from use of hydroxychloroquine in hospitalised patients with COVID-19
Biotechnology | COVID-19 | Infectious Disease | Therapeutics

No clinical benefit from use of hydroxychloroquine in hospitalised patients with COVID-19

On Jun. 5, 2020, the Chief Investigators of the randomised evaluation of COVid-19 thERapY (RECOVERY) trial on hydroxychloroquine…

Read More No clinical benefit from use of hydroxychloroquine in hospitalised patients with COVID-19Continue

Sorrento announced COVIDTRAP(STI-4398) demonstrated in preclinical studies its ability to completely inhibit SARS-CoV-2 viral infection In vitro
Biotechnology | COVID-19 | Therapeutics

Sorrento announced COVIDTRAP(STI-4398) demonstrated in preclinical studies its ability to completely inhibit SARS-CoV-2 viral infection In vitro

On Jun. 5, 2020, Sorrento announced it had completed a preclinical batch of the STI-4398 (COVIDTRAP) protein and…

Read More Sorrento announced COVIDTRAP(STI-4398) demonstrated in preclinical studies its ability to completely inhibit SARS-CoV-2 viral infection In vitroContinue

University of Queensland, CEPI and CSL partnered to advance development of COVID-19 vaccine candidate
Biotechnology | COVID-19 | Non-Profit Research | Vaccine

University of Queensland, CEPI and CSL partnered to advance development of COVID-19 vaccine candidate

On Jun. 5, 2020, CEPI, the Coalition for Epidemic Preparedness Innovations, CSL and The University of Queensland (UQ)…

Read More University of Queensland, CEPI and CSL partnered to advance development of COVID-19 vaccine candidateContinue

INOVIO and IVI Partnered with Seoul National University Hospital to start phase 1/2 clinical trial of COVID-19 DNA vaccine (INO-4800) in South Korea
Biotechnology | COVID-19 | Infectious Disease | Vaccine

INOVIO and IVI Partnered with Seoul National University Hospital to start phase 1/2 clinical trial of COVID-19 DNA vaccine (INO-4800) in South Korea

On Jun. 4, 2020, INOVIO and Seoul National University Hospital announced a partnership to start a Phase 1/2…

Read More INOVIO and IVI Partnered with Seoul National University Hospital to start phase 1/2 clinical trial of COVID-19 DNA vaccine (INO-4800) in South KoreaContinue

Page navigation

Previous PagePrevious 1 … 86 87 88 89 90 … 171 Next PageNext
  • Categories
  • Timeline
  • Agriculture
  • Artificial Intelligence
  • Biology
  • Biotechnology
  • Cardiovascular
  • Cartoons – Historical
  • Cartoons – Original
  • CDC
  • CDMO
  • Chemical
  • Clinical Research
  • Cloning
  • CMO
  • COVID-19
  • CRISPR
  • CRO
  • Cryogenic
  • Dentistry
  • Diagnostics
  • Disease
  • Energy
  • Environmental
  • EPA
  • FDA
  • Forestry
  • Genomics
  • HIV
  • Infectious Disease
  • Influenza
  • IRB
  • Life Science History
  • Marine Science
  • Materials
  • Measles
  • Medical Device
  • Medicine
  • Nanotechnology
  • Neurology
  • NIH
  • Non-Profit Research
  • Nutraceuticals
  • Oncology
  • Ophthalmogy
  • Organ Transplant
  • Orthopedic
  • Other
  • Pharmaceutical
  • Plague
  • Polio
  • Prehistory
  • Radiology
  • Rare Disease
  • Stem Cell
  • Therapeutics
  • U.S. Congress
  • Uncategorized
  • USDA
  • Vaccine
  • Veterinary
  • WHO
  • Women's Health
  • 2025
  • 2024
  • 2023
  • 2022
  • 2021
  • 2020
  • 2019
  • 2018
  • 2017
  • 2016
  • 2015
  • 2014
  • 2013
  • 2012
  • 2011
  • 2010
  • 2009
  • 2008
  • 2007
  • 2006
  • 2005
  • 2004
  • 2003
  • 2002
  • 2001
  • 2000
  • 1999
  • 1998
  • 1997
  • 1996
  • 1995
  • 1994
  • 1993
  • 1992
  • 1991
  • 1990
  • 1989
  • 1988
  • 1987
  • 1986
  • 1985
  • 1984
  • 1983
  • 1982
  • 1981
  • 1980
  • 1979
  • 1978
  • 1977
  • 1976
  • 1975
  • 1974
  • 1973
  • 1972
  • 1971
  • 1970
  • 1969
  • 1968
  • 1967
  • 1966
  • 1965
  • 1964
  • 1963
  • 1962
  • 1961
  • 1960
  • 1959
  • 1958
  • 1957
  • 1956
  • 1955
  • 1954
  • 1953
  • 1952
  • 1951
  • 1950
  • 1949
  • 1948
  • 1947
  • 1946
  • 1945
  • 1944
  • 1943
  • 1942
  • 1941
  • 1940
  • 1939
  • 1938
  • 1937
  • 1936
  • 1935
  • 1934
  • 1933
  • 1932
  • 1931
  • 1930
  • 1929
  • 1928
  • 1927
  • 1926
  • 1925
  • 1924
  • 1923
  • 1922
  • 1921
  • 1920
  • 1919
  • 1918
  • 1917
  • 1916
  • 1915
  • 1914
  • 1913
  • 1912
  • 1911
  • 1910
  • 1909
  • 1908
  • 1907
  • 1906
  • 1905
  • 1904
  • 1903
  • 1902
  • 1901
  • 1900
  • 1899
  • 1898
  • 1897
  • 1896
  • 1895
  • 1894
  • 1893
  • 1892
  • 1891
  • 1890
  • 1889
  • 1888
  • 1887
  • 1886
  • 1885
  • 1884
  • 1883
  • 1882
  • 1881
  • 1880
  • 1879
  • 1878
  • 1877
  • 1876
  • 1875
  • 1874
  • 1873
  • 1872
  • 1871
  • 1870
  • 1869
  • 1868
  • 1867
  • 1866
  • 1865
  • 1864
  • 1863
  • 1862
  • 1861
  • 1860
  • 1859
  • 1858
  • 1857
  • 1856
  • 1855
  • 1854
  • 1853
  • 1852
  • 1851
  • 1850
  • 1849
  • 1848
  • 1847
  • 1846
  • 1845
  • 1844
  • 1843
  • 1842
  • 1840
  • 1839
  • 1838
  • 1837
  • 1836
  • 1834
  • 1833
  • 1832
  • 1831
  • 1830
  • 1828
  • 1827
  • 1826
  • 1825
  • 1824
  • 1823
  • 1820
  • 1819
  • 1818
  • 1817
  • 1816
  • 1813
  • 1811
  • 1810
  • 1809
  • 1808
  • 1804
  • 1802
  • 1801
  • 1800
  • 1799
  • 1798
  • 1796
  • 1795
  • 1794
  • 1793
  • 1790
  • 1789
  • 1788
  • 1786
  • 1785
  • 1784
  • 1782
  • 1781
  • 1777
  • 1769
  • 1765
  • 1761
  • 1753
  • 1751
  • 1749
  • 1747
  • 1746
  • 1743
  • 1741
  • 1738
  • 1727
  • 1723
  • 1721
  • 1720
  • 1718
  • 1716
  • 1712
  • 1697
  • 1693
  • 1683
  • 1674
  • 1667
  • 1666
  • 1665
  • 1664
  • 1663
  • 1658
  • 1656
  • 1647
  • 1636
  • 1634
  • 1629
  • 1621
  • 1603
  • 1580
  • 1521
  • 1510
  • 1403
  • 1377
  • 1370
  • 1363
  • 1348
  • 1346
  • 1322
  • 1285
  • 1202
  • 1200
  • 1179
  • 1100
  • 1050
  • 541
  • 470
  • 1
Subscribe to E-History

Subscribe

* indicates required

LifeScienceHistory.com

LifeScienceHistory.com Where history is made daily, is a comprehensive companion of life science. Simply put, we dig history and we mine data.

More

  • About
  • Life Science Heroes

Advertising

  • Life Science Banner Advertising
  • Advertise Your Life Science Jobs

Legal

  • Privacy Policy
  • Terms of Use

© 2025 LifeScienceHistory.com by James Web Design

Facebook Instagram Linkedin
  • Home
  • Directory
    • General Company Directory
    • CRO Directory
    • CMO Directory
    • Genealogy on Demand
  • News and History
  • Cartoons
  • Small World
  • Earth is a Rock
    • Earth is a Rock
    • Earth is a Rock Lyrics
    • Earth is a Rock Lyrics Defined
Search